A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the diagnosis of adult GH deficiency in Japanese patients: A comparison
2013
Endocrine journal
Preserved Fulltext
It has been well recognized that adult GH deficiency (AGHD) is associated with a number of metabolic abnormalities and a decline in exercise capacity, and that GH replacement improves these impairments [1], but the treatment of AGHD is very expensive, with a high cost of long-term care and drug therapy. In Japan, hypopituitarism (including AGHD) was designated as a Specified Rare and Intractable Disease from October 2009, and the treatment of AGHD is publicly subsidized. Now, accurate diagnosis
doi:10.1507/endocrj.ej12-0230
pmid:23079545
fatcat:7t4gbmu62fcnhmnk4sih5mfiqi